Post-transplant sorafenib effectively prevents relapse in FLT3-mutated acute myeloid leukemia
SORA maintenance after HSCT diminishes the cumulative incidence of relapse as well as prolongs OS and RFS in FLT3-mutated AML.
Authors
- Aleksandra Butrym (ORCID: https://orcid.org/0000-0002-8199-2018)
- Agata Wieczorkiewicz-Kabut
- Anna Koclęga
- Anna Kopińska (ORCID: https://orcid.org/0000-0002-6821-7033)
- Krzysztof Woźniczka
- Patrycja Zielińska (ORCID: https://orcid.org/0000-0001-5215-5264)
- Grzegorz Helbig (ORCID: https://orcid.org/0000-0003-3703-1268)
- Adrianna Spałek (ORCID: https://orcid.org/0000-0001-9314-6292)
- Jarosław Czyż (ORCID: https://orcid.org/0000-0001-6779-7630)
Institutions
- Medical University of Silesia (PL)
- Nicolaus Copernicus University (PL)
Publication Details
- Journal
- Expert Review of Hematology
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1080/17474086.2025.2525453
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00